liu.seSök publikationer i DiVA
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Targeting the EGFR pathway for cancer therapy
University of Manitoba,Winnipeg, MB,R3E 0V9, Canada.
University of Manitoba,Winnipeg, MB,R3E 0V9, Canada.
University of Manitoba,Winnipeg, MB,R3E 0V9, Canada.
University of Manitoba,Winnipeg, MB,R3E 0V9, Canada.
Visa övriga samt affilieringar
2006 (Engelska)Ingår i: Current Medicinal Chemistry, ISSN 0929-8673, E-ISSN 1875-533X, Vol. 13, nr 29, s. 3483-3492Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Clinical studies have shown that HER-2/Neu is over-expressed in up to one-third of patients with a variety of cancers, including B-cell acute lymphoblastic leukemia (B-ALL), breast cancer and lung cancer, and that these patients are frequently resistant to conventional chemo-therapies. Additionally, in most patients with multiple myeloma, the malignant cells over-express a number of epidermal growth factor receptors (EGFR)s and their ligands, HB-EGF and amphiregulin, thus this growth-factor family may be an important aspect in the patho-biology of this disease. These and other, related findings have provided the rationale for the targeting of the components of the EGFR signaling pathways for cancer therapy. Below we discuss various aspects of EGFR-targeted therapies mainly in hematologic malignancies, lung cancer and breast cancer. Beside novel therapeutic approaches, we also discuss specific side effects associated with the therapeutic inhibition of components of the EGFR-pathways. Alongside small inhibitors, such as Lapatinib (Tykerb, GW572016), Gefitinib (Iressa, Z131839), and Erlotinib (Tarceva, OSI-774), a significant part of the review is also dedicated to therapeutic antibodies (e.g.: Trastuzumab / Herceptin, Pertuzumab / Omnitarg / rhuMab-2C4, Cetuximab / Erbitux / IMC-C225, Panitumumab / Abenix / ABX-EGF, and also ZD6474). In addition, we summarize, both current therapy development driven by antibody-based targeting of the EGFR-dependent signaling pathways, and furthermore, we provide a background on the history and the development of therapeutic antibodies.

Ort, förlag, år, upplaga, sidor
2006. Vol. 13, nr 29, s. 3483-3492
Nyckelord [en]
acute lymphoblastic-leukemia, acute myeloid-leukemia, cancer therapy, cell lung-cancer, cetuximab, egfr, erlotinib, gefitinib, growth-factor, lapatinib, metastatic breast-cancer, monoclonal-antibody, phase-ii trial, previously treated patients, randomized-trial, receptor tyrosine kinase, trastuzumab
Nationell ämneskategori
Cancer och onkologi Biokemi och molekylärbiologi Medicinsk bioteknologi (med inriktning mot cellbiologi (inklusive stamcellsbiologi), molekylärbiologi, mikrobiologi, biokemi eller biofarmaci)
Identifikatorer
URN: urn:nbn:se:liu:diva-86994DOI: 10.2174/092986706779026174ISI: 000242002600001OAI: oai:DiVA.org:liu-86994DiVA, id: diva2:584177
Tillgänglig från: 2013-01-08 Skapad: 2013-01-08 Senast uppdaterad: 2017-12-06

Open Access i DiVA

fulltext(81 kB)822 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 81 kBChecksumma SHA-512
2a69a00b66095810f9f21623eaa700ca4298f633c10e57a9f3db9eafd1ef7ae18b6b417b51accd9d1fd4c816ce08480e8a1aa62851b873f043210f2940eaa94e
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltext

Personposter BETA

Wiechec, EmiliaLos, Marek Jan

Sök vidare i DiVA

Av författaren/redaktören
Wiechec, EmiliaLos, Marek Jan
I samma tidskrift
Current Medicinal Chemistry
Cancer och onkologiBiokemi och molekylärbiologiMedicinsk bioteknologi (med inriktning mot cellbiologi (inklusive stamcellsbiologi), molekylärbiologi, mikrobiologi, biokemi eller biofarmaci)

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 822 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
urn-nbn

Altmetricpoäng

doi
urn-nbn
Totalt: 427 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf